カテゴリー： GlobalInfoResearch, 世界

関節リウマチおよびループス治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Rheumatoid Arthritis and Lupus Treatments Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102942）・商品コード：GIR9102942
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月24日（※2024年版があります。お問い合わせください）
・ページ数：121
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、関節リウマチおよびループス治療の世界市場について調べ、まとめました。種類別セグメントは、関節リウマチ治療、ループス治療等、用途別セグメントは、病院および診療所、外来手術センター、在宅ケア設定等に区分しました。関節リウマチおよびループス治療の世界市場概観、企業動向、企業別関節リウマチおよびループス治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・関節リウマチおよびループス治療の市場概観
・関節リウマチおよびループス治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・関節リウマチおよびループス治療の企業別販売動向、市場シェア、市場集中度、競争動向
・関節リウマチおよびループス治療の世界市場規模
・関節リウマチおよびループス治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・関節リウマチおよびループス治療のアメリカ市場規模推移
・関節リウマチおよびループス治療のカナダ市場規模推移
・関節リウマチおよびループス治療のメキシコ市場規模推移
・関節リウマチおよびループス治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・関節リウマチおよびループス治療のドイツ市場規模推移
・関節リウマチおよびループス治療のイギリス市場規模推移
・関節リウマチおよびループス治療のロシア市場規模推移
・関節リウマチおよびループス治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・関節リウマチおよびループス治療の日本市場規模推移
・関節リウマチおよびループス治療の中国市場規模推移
・関節リウマチおよびループス治療の韓国市場規模推移
・関節リウマチおよびループス治療のインド市場規模推移
・関節リウマチおよびループス治療の東南アジア市場規模推移
・関節リウマチおよびループス治療の南米市場分析（ブラジル、アルゼンチン等）
・関節リウマチおよびループス治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・関節リウマチおよびループス治療の種類別分析/販売量、売上、市場シェア（関節リウマチ治療、ループス治療）
・関節リウマチおよびループス治療の用途別分析/市場規模（病院および診療所、外来手術センター、在宅ケア設定）
・関節リウマチおよびループス治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・関節リウマチおよびループス治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system, multisystemic tissue and connective tissues.

Scope of the Report:
The global Rheumatoid Arthritis and Lupus Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rheumatoid Arthritis and Lupus Treatments.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rheumatoid Arthritis and Lupus Treatments market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rheumatoid Arthritis and Lupus Treatments market by product type and applications/end industries.

Market Segment by Companies, this report covers
AbbVie
Amgen
Bayer
Biogen Idec
Roche
Johnson and Johnson
Merck
Mitsubishi Tanabe Pharma
Novartis
Pfizer

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Rheumatoid Arthritis Treatments
Lupus Treatments

Market Segment by Applications, can be divided into
Hospitals and Clinics
Ambulatory Surgery Centers
Homecare Settings

【レポートの目次】

Table of Contents

1 Rheumatoid Arthritis and Lupus Treatments Market Overview
1.1 Product Overview and Scope of Rheumatoid Arthritis and Lupus Treatments
1.2 Classification of Rheumatoid Arthritis and Lupus Treatments by Types
1.2.1 Global Rheumatoid Arthritis and Lupus Treatments Revenue Comparison by Types (2019-2024)
1.2.2 Global Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Types in 2018
1.2.3 Rheumatoid Arthritis Treatments
1.2.4 Lupus Treatments
1.3 Global Rheumatoid Arthritis and Lupus Treatments Market by Application
1.3.1 Global Rheumatoid Arthritis and Lupus Treatments Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgery Centers
1.3.4 Homecare Settings
1.4 Global Rheumatoid Arthritis and Lupus Treatments Market by Regions
1.4.1 Global Rheumatoid Arthritis and Lupus Treatments Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Rheumatoid Arthritis and Lupus Treatments Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rheumatoid Arthritis and Lupus Treatments Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rheumatoid Arthritis and Lupus Treatments Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Rheumatoid Arthritis and Lupus Treatments Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rheumatoid Arthritis and Lupus Treatments Status and Prospect (2014-2024)
1.5 Global Market Size of Rheumatoid Arthritis and Lupus Treatments (2014-2024)
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Rheumatoid Arthritis and Lupus Treatments Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Rheumatoid Arthritis and Lupus Treatments Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Rheumatoid Arthritis and Lupus Treatments Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.4 Biogen Idec
2.4.1 Business Overview
2.4.2 Rheumatoid Arthritis and Lupus Treatments Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biogen Idec Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.5 Roche
2.5.1 Business Overview
2.5.2 Rheumatoid Arthritis and Lupus Treatments Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.6 Johnson and Johnson
2.6.1 Business Overview
2.6.2 Rheumatoid Arthritis and Lupus Treatments Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson and Johnson Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck
2.7.1 Business Overview
2.7.2 Rheumatoid Arthritis and Lupus Treatments Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.8 Mitsubishi Tanabe Pharma
2.8.1 Business Overview
2.8.2 Rheumatoid Arthritis and Lupus Treatments Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mitsubishi Tanabe Pharma Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.9 Novartis
2.9.1 Business Overview
2.9.2 Rheumatoid Arthritis and Lupus Treatments Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Rheumatoid Arthritis and Lupus Treatments Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rheumatoid Arthritis and Lupus Treatments Market Competition, by Players
3.1 Global Rheumatoid Arthritis and Lupus Treatments Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Rheumatoid Arthritis and Lupus Treatments Players Market Share
3.2.2 Top 10 Rheumatoid Arthritis and Lupus Treatments Players Market Share
3.3 Market Competition Trend
4 Global Rheumatoid Arthritis and Lupus Treatments Market Size by Regions
4.1 Global Rheumatoid Arthritis and Lupus Treatments Revenue and Market Share by Regions
4.2 North America Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
4.3 Europe Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
4.5 South America Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
5 North America Rheumatoid Arthritis and Lupus Treatments Revenue by Countries
5.1 North America Rheumatoid Arthritis and Lupus Treatments Revenue by Countries (2014-2019)
5.2 USA Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
5.3 Canada Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
5.4 Mexico Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
6 Europe Rheumatoid Arthritis and Lupus Treatments Revenue by Countries
6.1 Europe Rheumatoid Arthritis and Lupus Treatments Revenue by Countries (2014-2019)
6.2 Germany Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
6.3 UK Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
6.4 France Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
6.5 Russia Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
6.6 Italy Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Rheumatoid Arthritis and Lupus Treatments Revenue by Countries
7.1 Asia-Pacific Rheumatoid Arthritis and Lupus Treatments Revenue by Countries (2014-2019)
7.2 China Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
7.3 Japan Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
7.4 Korea Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
7.5 India Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
8 South America Rheumatoid Arthritis and Lupus Treatments Revenue by Countries
8.1 South America Rheumatoid Arthritis and Lupus Treatments Revenue by Countries (2014-2019)
8.2 Brazil Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
8.3 Argentina Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
8.4 Colombia Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Rheumatoid Arthritis and Lupus Treatments by Countries
9.1 Middle East and Africa Rheumatoid Arthritis and Lupus Treatments Revenue by Countries (2014-2019)
9.2 Saudi Arabia Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
9.3 UAE Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
9.4 Egypt Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
9.5 Nigeria Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
9.6 South Africa Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
10 Global Rheumatoid Arthritis and Lupus Treatments Market Segment by Type
10.1 Global Rheumatoid Arthritis and Lupus Treatments Revenue and Market Share by Type (2014-2019)
10.2 Global Rheumatoid Arthritis and Lupus Treatments Market Forecast by Type (2019-2024)
10.3 Rheumatoid Arthritis Treatments Revenue Growth Rate (2014-2024)
10.4 Lupus Treatments Revenue Growth Rate (2014-2024)
11 Global Rheumatoid Arthritis and Lupus Treatments Market Segment by Application
11.1 Global Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Application (2014-2019)
11.2 Rheumatoid Arthritis and Lupus Treatments Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2014-2019)
11.4 Ambulatory Surgery Centers Revenue Growth (2014-2019)
11.5 Homecare Settings Revenue Growth (2014-2019)
12 Global Rheumatoid Arthritis and Lupus Treatments Market Size Forecast (2019-2024)
12.1 Global Rheumatoid Arthritis and Lupus Treatments Market Size Forecast (2019-2024)
12.2 Global Rheumatoid Arthritis and Lupus Treatments Market Forecast by Regions (2019-2024)
12.3 North America Rheumatoid Arthritis and Lupus Treatments Revenue Market Forecast (2019-2024)
12.4 Europe Rheumatoid Arthritis and Lupus Treatments Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Rheumatoid Arthritis and Lupus Treatments Revenue Market Forecast (2019-2024)
12.6 South America Rheumatoid Arthritis and Lupus Treatments Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Rheumatoid Arthritis and Lupus Treatments Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Rheumatoid Arthritis and Lupus Treatments Picture
Table Product Specifications of Rheumatoid Arthritis and Lupus Treatments
Table Global Rheumatoid Arthritis and Lupus Treatments and Revenue (Million USD) Market Split by Product Type
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Types in 2018
Figure Rheumatoid Arthritis Treatments Picture
Figure Lupus Treatments Picture
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) by Application (2014-2024)
Figure Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Applications in 2018
Figure Hospitals and Clinics Picture
Figure Ambulatory Surgery Centers Picture
Figure Homecare Settings Picture
Table Global Market Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Rheumatoid Arthritis and Lupus Treatments Type and Applications
Table AbbVie Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Rheumatoid Arthritis and Lupus Treatments Type and Applications
Table Amgen Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Rheumatoid Arthritis and Lupus Treatments Type and Applications
Table Bayer Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Rheumatoid Arthritis and Lupus Treatments Type and Applications
Table Biogen Idec Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Rheumatoid Arthritis and Lupus Treatments Type and Applications
Table Roche Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson and Johnson Rheumatoid Arthritis and Lupus Treatments Type and Applications
Table Johnson and Johnson Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Rheumatoid Arthritis and Lupus Treatments Type and Applications
Table Merck Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table Mitsubishi Tanabe Pharma Rheumatoid Arthritis and Lupus Treatments Type and Applications
Table Mitsubishi Tanabe Pharma Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Rheumatoid Arthritis and Lupus Treatments Type and Applications
Table Novartis Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Rheumatoid Arthritis and Lupus Treatments Type and Applications
Table Pfizer Rheumatoid Arthritis and Lupus Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) by Players (2014-2019)
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue Share by Players (2014-2019)
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue Share by Players in 2017
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue Share by Players in 2018
Figure Global Top 5 Players Rheumatoid Arthritis and Lupus Treatments Revenue Market Share in 2018
Figure Global Top 10 Players Rheumatoid Arthritis and Lupus Treatments Revenue Market Share in 2018
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) by Regions (2014-2019)
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Regions (2014-2019)
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Regions (2014-2019)
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Regions in 2018
Figure North America Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Europe Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure South America Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Table North America Rheumatoid Arthritis and Lupus Treatments Revenue by Countries (2014-2019)
Table North America Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries (2014-2019)
Figure North America Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries (2014-2019)
Figure North America Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries in 2018
Figure USA Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Canada Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Mexico Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Table Europe Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) by Countries (2014-2019)
Figure Europe Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries (2014-2019)
Figure Europe Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries in 2018
Figure Germany Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure UK Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure France Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Russia Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Italy Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries in 2018
Figure China Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Japan Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Korea Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure India Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Table South America Rheumatoid Arthritis and Lupus Treatments Revenue by Countries (2014-2019)
Table South America Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries (2014-2019)
Figure South America Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries (2014-2019)
Figure South America Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries in 2018
Figure Brazil Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Argentina Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Colombia Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rheumatoid Arthritis and Lupus Treatments Revenue Market Share by Countries in 2018
Figure Saudi Arabia Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure UAE Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Egypt Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure Nigeria Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Figure South Africa Rheumatoid Arthritis and Lupus Treatments Revenue and Growth Rate (2014-2019)
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) by Type (2014-2019)
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue Share by Type (2014-2019)
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue Share by Type (2014-2019)
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue Share by Type in 2019
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue Forecast by Type (2019-2024)
Figure Global Rheumatoid Arthritis and Lupus Treatments Market Share Forecast by Type (2019-2024)
Figure Global Rheumatoid Arthritis Treatments Revenue Growth Rate (2014-2019)
Figure Global Lupus Treatments Revenue Growth Rate (2014-2019)
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue by Application (2014-2019)
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue Share by Application (2014-2019)
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue Share by Application (2014-2019)
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue Share by Application in 2019
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue Forecast by Application (2019-2024)
Figure Global Rheumatoid Arthritis and Lupus Treatments Market Share Forecast by Application (2019-2024)
Figure Global Hospitals and Clinics Revenue Growth Rate (2014-2019)
Figure Global Ambulatory Surgery Centers Revenue Growth Rate (2014-2019)
Figure Global Homecare Settings Revenue Growth Rate (2014-2019)
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Rheumatoid Arthritis and Lupus Treatments Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Rheumatoid Arthritis and Lupus Treatments Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Rheumatoid Arthritis and Lupus Treatments Revenue Market Forecast (2019-2024)
Figure Europe Rheumatoid Arthritis and Lupus Treatments Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Rheumatoid Arthritis and Lupus Treatments Revenue Market Forecast (2019-2024)
Figure South America Rheumatoid Arthritis and Lupus Treatments Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Rheumatoid Arthritis and Lupus Treatments Revenue Market Forecast (2019-2024)


【掲載企業】

AbbVie、Amgen、Bayer、Biogen Idec、Roche、Johnson and Johnson、Merck、Mitsubishi Tanabe Pharma、Novartis、Pfizer、

★調査レポート[関節リウマチおよびループス治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102942)販売に関する免責事項を必ずご確認ください。
★調査レポート[関節リウマチおよびループス治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 乾癬性関節炎（PsA）治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103337 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、乾癬性関節炎（PsA）治療の世界市場について調べ、まとめました。種類別セグメントは、非ステロイド系抗炎症薬、疾患修飾性抗リウマチ薬、生物製剤等、用途別セグメントは、病院、診療所、その他等に区分しました。乾癬性関節炎（PsA）治療の世界市場概観、企業動向、企業別乾癬性関節炎（PsA）治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・乾癬性関節炎（PsA）治療の市場概観 ・乾癬性関節炎（PsA）治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・乾癬性関節炎（PsA）治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・乾癬性関節炎（PsA）治療の世界市場規模 ・乾癬性関節炎（PsA）治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・乾癬性関節炎（PsA）治療のアメリカ市場規模推移 ・乾癬性関節炎（PsA）治療のカナダ市場規模推移 ・乾癬性関節炎（PsA）治療のメキシコ市場規模推移 ・乾癬性関節炎（PsA）治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Psoriatic Arthritis (PsA) Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Psoriatic Arthritis (PsA) Treatment. Europe also play important...
  • 処方関節炎薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101544 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、処方関節炎薬の世界市場について調べ、まとめました。種類別セグメントは、経口、局所等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。処方関節炎薬の世界市場概観、メーカー動向、メーカー別処方関節炎薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・処方関節炎薬の市場概観 ・処方関節炎薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・処方関節炎薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・処方関節炎薬の世界市場規模 ・処方関節炎薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・処方関節炎薬のアメリカ市場規模推移 ・処方関節炎薬のカナダ市場規模推移 ・処方関節炎薬のメキシコ市場規模推移 ・処方関節炎薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms. Scope of the Report: The worldwide market for Prescription Arthritis Medications is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Prescription Arthritis Medications in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type...
  • サイトメガロウイルス病治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101582 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、サイトメガロウイルス病治療の世界市場について調べ、まとめました。種類別セグメントは、ガンシクロビル、バルガンシクロビル、フォスカルネット、シドフォビル、その他等、用途別セグメントは、幹細胞移植、臓器移植、先天性CMV感染、その他等に区分しました。サイトメガロウイルス病治療の世界市場概観、企業動向、企業別サイトメガロウイルス病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・サイトメガロウイルス病治療の市場概観 ・サイトメガロウイルス病治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・サイトメガロウイルス病治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・サイトメガロウイルス病治療の世界市場規模 ・サイトメガロウイルス病治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・サイトメガロウイルス病治療のアメリカ市場規模推移 ・サイトメガロウイルス病治療のカナダ市場規模推移 ・サイトメガロウイルス病治療のメキシコ市場規模推移 ・サイトメガロウイルス病治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Cytomegalovirus disease (CMV) is a viral infection that can affect one part of the body, such as the eyes, or it can spread throughout the body. Scope of the Report: The global Cytomegalovirus Disease Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important...

    • ◆H&Iグローバルリサーチのお客様（例）◆